Menu
Visit our distribution portal.
News & Events

IMCoPharma enters into a binding Term sheet with Barentz to sell majority share in the company

IMCoPharma enters into a binding Term sheet with Barentz to sell majority share in the company

During CPhI 2019 in Frankfurt there was signed a Term sheet between a founder and CEO of IMCoPharma, Mr. Ivan Mikes and Mr. Hidde van der Wal, CEO of BARENTZ. By this document there has been formally started the process of Barentz's acquisition of majority share in IMCoPharma. You may take a look at photos in the gallery.

Leave us a message